A 1% colloidal oatmeal OTC cream is clinically effective for the management of mild to moderate atopic dermatitis in Black or African American children

References

• Lifschitz C. The impact of atopic dermatitis on quality of life. Ann Nutr Metab. 2015;66(suppl 1):1–8. doi: 10.1159/000370226.
   Google Scholar
• Beattie PE, Lewis-Jones MS. A comparative study of impairment of quality of life in children with skin disease and children with other chronic childhood diseases. Br J Dermatol. 2006;155(1):145–151. doi: 10.1111/j.1365-2133.2006.07185.x.
   PubMed Web of Science ®Google Scholar
• Fujita H, Shemer A, Suárez-Fariñas M, et al. Lesional dendritic cells in patients with chronic atopic dermatitis and psoriasis exhibit parallel ability to activate T-cell subsets. J Allergy Clin Immunol. 2011;128(3):574–582. doi: 10.1016/j.jaci.2011.05.016.
   PubMed Web of Science ®Google Scholar
• Gittler JK, Shemer A, Suárez-Fariñas M, et al. Progressive activation of TH2/TH22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis. J Allergy Clin Immunol. 2012;130(6):1344–1354. doi: 10.1016/j.jaci.2012.07.012.
   PubMed Web of Science ®Google Scholar
• Khattri S, Shemer A, Rozenblit M, et al. Cyclosporine in atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology. J Allergy Clin Immunol. 2014;133(6):1626–1634. doi: 10.1016/j.jaci.2014.03.003.
   PubMed Web of Science ®Google Scholar
• Agrawal R, Woodfolk JA. Skin barrier defects in atopic dermatitis. Curr Allergy Asthma Rep. 2014;14(5):433. doi: 10.1007/s11882-014-0433-9.
   PubMed Web of Science ®Google Scholar
• Blaess M, Deigner HP. Derailed ceramide metabolism in atopic dermatitis (AD): a causal starting point for a personalized (basic) therapy. Int J Mol Sci. 2019;20(16):3967. doi: 10.3390/ijms20163967.
   PubMed Web of Science ®Google Scholar
• Fowler JF, Nebus J, Wallo W, et al. Colloidal oatmeal formulations as adjunct treatments in atopic dermatitis. J Drugs Dermatol. 2012;11(7):804–807.
   PubMed Web of Science ®Google Scholar
• Lisante TA, Nuñez C, Zhang P. Efficacy and safety of an over-the-counter 1% colloidal oatmeal cream in the management of mild to moderate atopic dermatitis in children: a double-blind, randomized, active-controlled study. J Dermatolog Treat. 2017;28(7):659–667. doi: 10.1080/09546634.2017.1303569.
   PubMed Web of Science ®Google Scholar
• Shaw TE, Currie GP, Koudelka CW, et al. Eczema prevalence in the United States: data from the 2003 National Survey of Children’s Health. J Invest Dermatol. 2011;131(1):67–73. doi: 10.1038/jid.2010.251.
   PubMed Web of Science ®Google Scholar
• Ullah F, Kaelber DC. Using large aggregated de-identified electronic health record data to determine the prevalence of common chronic diseases in pediatric patients who visited primary care clinics. Acad Pediatr. 2021;21(6):1084–1093. doi: 10.1016/j.acap.2021.05.007.
   PubMed Web of Science ®Google Scholar
• Fu T, Keiser E, Linos E, et al. Eczema and sensitization to common allergens in the United States: a multiethnic, population-based study. Pediatr Dermatol. 2014;31(1):21–26. doi: 10.1111/pde.12237.
   PubMed Web of Science ®Google Scholar
• Ait-Khaled N, Odhiambo J, Pearce N, et al. Prevalence of symptoms of asthma, rhinitis and eczema in 13- to 14-year-old children in Africa: the International Study of Asthma and Allergies in Childhood Phase III. Allergy. 2007;62(3):247–258. doi: 10.1111/j.1398-9995.2007.01325.x.
   PubMed Web of Science ®Google Scholar
• Janumpally SR, Feldman SR, Gupta AK, et al. In the United States, blacks and Asian/Pacific Islanders are more likely than whites to seek medical care for atopic dermatitis. Arch Dermatol. 2002;138(5):634–637. doi: 10.1001/archderm.138.5.634.
   PubMedGoogle Scholar
• Kaufman BP, Guttman-Yassky E, Alexis AF. Atopic dermatitis in diverse racial and ethnic groups—variations in epidemiology, genetics, clinical presentation and treatment. Exp Dermatol. 2018;27(4):340–357. doi: 10.1111/exd.13514.
   PubMed Web of Science ®Google Scholar
• Brunner PM, Guttman-Yassky E. Racial differences in atopic dermatitis. Ann Allergy Asthma Immunol. 2019;122(5):449–455. doi: 10.1016/j.anai.2018.11.015.
   PubMed Web of Science ®Google Scholar
• Ben-Gashir MA, Hay RJ. Reliance on erythema scores may mask severe atopic dermatitis in black children compared with their white counterparts. Br J Dermatol. 2002;147(5):920–925. doi: 10.1046/j.1365-2133.2002.04965.x.
   PubMed Web of Science ®Google Scholar
• Hengge UR, Ruzicka T, Schwartz RA, et al. Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol. 2006;54(1):1–15. doi: 10.1016/j.jaad.2005.01.010.
   PubMed Web of Science ®Google Scholar
• Proksch E, Fölster-Holst R, Bräutigam M, et al. Role of the epidermal barrier in atopic dermatitis. J Dtsch Dermatol Ges. 2009;7(10):899–910. doi: 10.1111/j.1610-0387.2009.07157.x.
   PubMed Web of Science ®Google Scholar
• Wilson D, Berardesca E, Maibach HI. In vitro transepidermal water loss: differences between black and white human skin. Br J Dermatol. 1988;119(5):647–652. doi: 10.1111/j.1365-2133.1988.tb03478.x.
   PubMed Web of Science ®Google Scholar
• Jungersted JM, Høgh JK, Hellgren LI, et al. Ethnicity and stratum corneum ceramides. Br J Dermatol. 2010;163(6):1169–1173. doi: 10.1111/j.1365-2133.2010.10080.x.
   PubMed Web of Science ®Google Scholar
• Leung DY, Guttman-Yassky E. Deciphering the complexities of atopic dermatitis: shifting paradigms in treatment approaches. J Allergy Clin Immunol. 2014;134(4):769–779. doi: 10.1016/j.jaci.2014.08.008.
   PubMed Web of Science ®Google Scholar
• Eichenfield LF, Hanifin JM, Luger TA, et al. Consensus conference on pediatric atopic dermatitis. J Am Acad Dermatol. 2003;49(6):1088–1095. doi: 10.1016/s0190-9622(03)02539-8.
   PubMedGoogle Scholar
• Akdis CA, Akdis M, Bieber T, et al. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL consensus report. J Allergy Clin Immunol. 2006;118(1):152–169. doi: 10.1016/j.jaci.2006.03.045.
   PubMed Web of Science ®Google Scholar
• Eichenfield LF, Tom WL, Berger TG, et al. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol. 2014;71(1):116–132. doi: 10.1016/j.jaad.2014.03.023.
   PubMed Web of Science ®Google Scholar
• Van Bever HPS, Llanora G. Features of childhood atopic dermatitis. Asian Pac J Allergy Immunol. 2011;29(1):15–24.
   PubMed Web of Science ®Google Scholar
• Allais B, Friedman A. ARTICLE: colloidal oatmeal part I: history, basic science, mechanism of action, and clinical efficacy in the treatment of atopic dermatitis. J Drugs Dermatol. 2020;19(10):s4–s7.
   PubMed Web of Science ®Google Scholar
• Kurtz ES, Wallo W. Colloidal oatmeal: history, chemistry and clinical properties. J Drugs Dermatol. 2007;6(2):167–170.
   PubMedGoogle Scholar
• Cerio R, Dohil M, Jeanine D, et al. Mechanism of action and clinical benefits of colloidal oatmeal for dermatologic practice. J Drugs Dermatol. 2010;9(9):1116–1120.
   PubMed Web of Science ®Google Scholar
• FDA.gov. CFR - Code of Federal Regulations Title 21, Chapter I, Subchapter D, Part 347 Skin protectant drug products for over-the-counter human use. 2022. [cited 2021 Jun 16]. Available from: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=347&showFR=1.
   Google Scholar
• Primus Pharmaceuticals. Epiceram® controlled release skin barrier emulsion. 2018. [cited 2021 Jun 16]. Available from: https://www.epiceramrx.com/assets/pdfs/prescribing-information/epiceram-pi.pdf.
   Google Scholar
• Hanifin J, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol. 1980;60:44–47. doi: 10.2340/00015555924447.
   Google Scholar
• Hanifin JM, Thurston M, Omoto M, et al. The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. Exp Dermatol. 2001;10(1):11–18. doi: 10.1034/j.1600-0625.2001.100102.x.
   PubMed Web of Science ®Google Scholar
• Silverberg JI. Public health burden and epidemiology of atopic dermatitis. Dermatol Clin. 2017;35(3):283–289. doi: 10.1016/j.det.2017.02.002.
   PubMed Web of Science ®Google Scholar
• Hirano SA, Murray SB, Harvey VM. Reporting, representation, and subgroup analysis of race and ethnicity in published clinical trials of atopic dermatitis in the United States between 2000 and 2009. Pediatr Dermatol. 2012;29(6):749–755. doi: 10.1111/j.1525-1470.2012.01797.x.
   PubMed Web of Science ®Google Scholar
• Nebus J, Wallo W, Fowler J. Evaluating the safety and tolerance of a body wash and moisturizing regimen in patients with atopic dermatitis. J Am Acad Dermatol. 2007;56(suppl 2)(2):AB71.
   Web of Science ®Google Scholar
• Nebus J, Nystrand G, Fowler J, et al. A daily oat-based skin care regimen for atopic skin. J Am Acad Dermatol. 2009;60(suppl 1)(3):AB67.
   Web of Science ®Google Scholar
• Weber TM, Babcock MJ, Herndon Jr. JH, et al. Steroid-free emollient formulations reduce symptoms of eczema and improve quality of life. J Drugs Dermatol. 2014;13(5):589–595.
   PubMed Web of Science ®Google Scholar
• Adams C, Chatterjee A, Harder BM, et al. Beyond unequal access: acculturation, race, and resistance to pharmaceuticalization in the United States. SSM Popul Health. 2018;4:350–357. doi: 10.1016/j.ssmph.2018.04.003.
   PubMed Web of Science ®Google Scholar
• Hebert AA, Rippke F, Weber TM, et al. Efficacy of nonprescription moisturizers for atopic dermatitis: an updated review of clinical evidence. Am J Clin Dermatol. 2020;21(5):641–655. doi: 10.1007/s40257-020-00529-9.
   PubMed Web of Science ®Google Scholar
• Medicaid.gov. July 2022 Medicaid & CHIP enrollment data highlights. 2022. [cited 2022 Nov 14]. Available from: https://www.medicaid.gov/medicaid/program-information/medicaid-and-chip-enrollment-data/report-highlights/index.html.
   Google Scholar
• Brooks T, Gardner A. Snapshot of children with Medicaid by race and ethnicity, 2018. 2020. [cited 2022 Nov 14]. Available from: https://ccf.georgetown.edu/wp-content/uploads/2020/07/Snapshot-Medicaid-kids-race-ethnicity-v4.pdf.
   Google Scholar
• Kamara M, Kuo AM, Stein SL, et al. Disparities in availability of skin therapies found in public assistance formularies. J Am Acad Dermatol. 2022;87(2):411–417. doi: 10.1016/j.jaad.2021.08.033.
   PubMed Web of Science ®Google Scholar
• Bell MA, Whang KA, Thomas J, et al. Racial and ethnic disparities in access to emerging and frontline therapies in common dermatological conditions: a cross-sectional study. J Natl Med Assoc. 2020;112(6):650–653. doi: 10.1016/j.jnma.2020.06.009.
   PubMed Web of Science ®Google Scholar